BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 18295483)

  • 1. Design and structure-activity relationships of potent and selective inhibitors of undecaprenyl pyrophosphate synthase (UPPS): tetramic, tetronic acids and dihydropyridin-2-ones.
    Peukert S; Sun Y; Zhang R; Hurley B; Sabio M; Shen X; Gray C; Dzink-Fox J; Tao J; Cebula R; Wattanasin S
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1840-4. PubMed ID: 18295483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in the Development of Undecaprenyl Pyrophosphate Synthase Inhibitors as Potential Antibacterials.
    Jukic M; Rozman K; Gobec S
    Curr Med Chem; 2016; 23(5):464-82. PubMed ID: 26718796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical investigation of the mode of inhibition of tetramic acids, the allosteric inhibitors of undecaprenyl pyrophosphate synthase.
    Lee LV; Granda B; Dean K; Tao J; Liu E; Zhang R; Peukert S; Wattanasin S; Xie X; Ryder NS; Tommasi R; Deng G
    Biochemistry; 2010 Jun; 49(25):5366-76. PubMed ID: 20476728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase.
    Danley DE; Baima ET; Mansour M; Fennell KF; Chrunyk BA; Mueller JP; Liu S; Qiu X
    Protein Sci; 2015 Jan; 24(1):20-6. PubMed ID: 25287857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of cis-prenyltransferase reaction probed by substrate analogues.
    Lu YP; Liu HG; Teng KH; Liang PH
    Biochem Biophys Res Commun; 2010 Oct; 400(4):758-62. PubMed ID: 20828539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetramic and tetronic acids: an update on new derivatives and biological aspects.
    Schobert R; Schlenk A
    Bioorg Med Chem; 2008 Apr; 16(8):4203-21. PubMed ID: 18334299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and Characterization of a Class of Pyrazole Inhibitors of Bacterial Undecaprenyl Pyrophosphate Synthase.
    Concha N; Huang J; Bai X; Benowitz A; Brady P; Grady LC; Kryn LH; Holmes D; Ingraham K; Jin Q; Pothier Kaushansky L; McCloskey L; Messer JA; O'Keefe H; Patel A; Satz AL; Sinnamon RH; Schneck J; Skinner SR; Summerfield J; Taylor A; Taylor JD; Evindar G; Stavenger RA
    J Med Chem; 2016 Aug; 59(15):7299-304. PubMed ID: 27379833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of triton concentration on the activity of undecaprenyl pyrophosphate synthase inhibitors.
    Li H; Huang J; Jiang X; Seefeld M; McQueney M; Macarron R
    J Biomol Screen; 2003 Dec; 8(6):712-5. PubMed ID: 14711397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of tetramic and tetronic acids as beta-secretase inhibitors.
    Larbig G; Schmidt B
    J Comb Chem; 2006; 8(4):480-90. PubMed ID: 16827559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the active conformation and the importance of length of the flexible loop 72-83 in regulating the conformational change of undecaprenyl pyrophosphate synthase.
    Chang SY; Chen YK; Wang AH; Liang PH
    Biochemistry; 2003 Dec; 42(49):14452-9. PubMed ID: 14661956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.
    Williams TM; Ciccarone TM; MacTough SC; Bock RL; Conner MW; Davide JP; Hamilton K; Koblan KS; Kohl NE; Kral AM; Mosser SD; Omer CA; Pompliano DL; Rands E; Schaber MD; Shah D; Wilson FR; Gibbs JB; Graham SL; Hartman GD; Oliff AI; Smith RL
    J Med Chem; 1996 Mar; 39(7):1345-8. PubMed ID: 8691462
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and application of a fluorescent substrate analogue to study ligand interactions for undecaprenyl pyrophosphate synthase.
    Chen AP; Chen YH; Liu HP; Li YC; Chen CT; Liang PH
    J Am Chem Soc; 2002 Dec; 124(51):15217-24. PubMed ID: 12487597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK.
    Ozawa T; Kitagawa H; Yamamoto Y; Takahata S; Iida M; Osaki Y; Yamada K
    Bioorg Med Chem; 2007 Dec; 15(23):7325-36. PubMed ID: 17892940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures, mechanisms and inhibitors of undecaprenyl diphosphate synthase: a cis-prenyltransferase for bacterial peptidoglycan biosynthesis.
    Teng KH; Liang PH
    Bioorg Chem; 2012 Aug; 43():51-7. PubMed ID: 21993493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective synthesis and glycosidase inhibitory activity of 3,4-dihydroxy-pyrrolidin-2-one, 3,4-dihydroxy-piperidin-2-one and 1,2-dihydroxy-pyrrolizidin-3-one.
    Coutrot P; Claudel S; Didierjean C; Grison C
    Bioorg Med Chem Lett; 2006 Jan; 16(2):417-20. PubMed ID: 16271473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR.
    Deak HL; Newcomb JR; Nunes JJ; Boucher C; Cheng AC; DiMauro EF; Epstein LF; Gallant P; Hodous BL; Huang X; Lee JH; Patel VF; Schneider S; Turci SM; Zhu X
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1172-6. PubMed ID: 18083554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-thiol farnesyltransferase inhibitors: N-(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides.
    Kettler K; Sakowski J; Silber K; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2003 Apr; 11(7):1521-30. PubMed ID: 12705292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis.
    Guo RT; Ko TP; Chen AP; Kuo CJ; Wang AH; Liang PH
    J Biol Chem; 2005 May; 280(21):20762-74. PubMed ID: 15788389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epi-trichosetin, a new undecaprenyl pyrophosphate synthase inhibitor, produced by Fusarium oxysporum FKI-4553.
    Inokoshi J; Shigeta N; Fukuda T; Uchida R; Nonaka K; Masuma R; Tomoda H
    J Antibiot (Tokyo); 2013 Sep; 66(9):549-54. PubMed ID: 23715038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.
    Mitsch A; Wissner P; Silber K; Haebel P; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2004 Sep; 12(17):4585-600. PubMed ID: 15358286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.